太阳集团tyc5997_平台(china)官方网站

神经钙黏蛋白(NCAD)多克隆抗体

Polyclonal Antibody to N-cadherin (NCAD)

CDw325; CD325; CDHN; CDH2; Cadherin 2 Type 1; N-Cadherin

  • 神经钙黏蛋白(NCAD)多克隆抗体 产品包装(模拟)
  • 神经钙黏蛋白(NCAD)多克隆抗体 产品包装(模拟)
  • 神经钙黏蛋白(NCAD)多克隆抗体 IHC图
  • PAB481Ra03.jpg Figure. Western Blot; Sample: Recombinant CDH2, Rat.
  • 神经钙黏蛋白(NCAD)多克隆抗体 Western Blot; Samples: Lane1: Mouse Heart lysate; Lane2: Rat Cerebrum lysate;
    Primary Ab: 0.2µg/ml Rabbit Anti-Rat NCAD Antibody
    Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对NCAD的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别NCAD。

用法

Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

赠品

相关产品

编号 适用物种：Rattus norvegicus (Rat，大鼠) 应用(仅供研究使用，不用于临床诊断！)
RPB481Ra02 神经钙黏蛋白(NCAD)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB481Ra03 神经钙黏蛋白(NCAD)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB481Ra01 神经钙黏蛋白(NCAD)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAB481Ra02 神经钙黏蛋白(NCAD)多克隆抗体 WB; IHC; ICC; IP.
PAB481Ra03 神经钙黏蛋白(NCAD)多克隆抗体 WB; IHC; ICC; IP.
PAB481Ra01 神经钙黏蛋白(NCAD)多克隆抗体 WB; IHC; ICC; IP.
LAB481Ra71 神经钙黏蛋白(NCAD)多克隆抗体(生物素标记) WB; IHC; ICC.

参考文献

杂志 参考文献
Toxicology Letters Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients. [Pubmed: 23830989]
British journal of haematology Circulating N-cadherin levels are a negative prognostic indicator in patients with multiple myeloma. [Pubmed: 23438504]
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY Elevated Cerebrospinal Fluid and Plasma N-Cadherin in Alzheimer Disease [Pubmed: 32296844]
Cell Biol Toxicol ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer [33566221]
CELL BIOLOGY AND TOXICOLOGY Metastatic suppression by DOC2B is mediated by inhibition of epithelial-mesenchymal transition and induction of senescence [33758996]
Pharmacol Res DOC2B is a Negative Regulator of Wnt/β-catenin Signaling Pathway in Cervical Cancer [Pubmed:35500882]
留言咨询
Baidu
sogou